New Data on EVO100 for the Prevention of Chlamydia and Gonorrhea in Women to be Presented at ISPOR 2021

SAN DIEGO, May 17, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that new research on its investigational drug EVO100 for the prevention of chlamydia and gonorrhea in women will be highlighted in a poster presentation at the annual meeting of the…

About the Author

has written 41802 stories on this site.

Copyright © 2010 Business and Corporate News.